Pages that link to "Q28168895"

The following pages link to Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells (Q28168895):

Displaying 28 items.

• Sulindac suppresses beta-catenin expression in human cancer cells (Q24316103) (← links)
• The Wnt-dependent signaling pathways as target in oncology drug discovery (Q24652979) (← links)
• Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets (Q27004250) (← links)
• Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled (Q27656739) (← links)
• Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα (Q28479206) (← links)
• Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors (Q28546685) (← links)
• The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling (Q33292094) (← links)
• A direct protein-protein interaction is involved in the suppression of beta-catenin transcription by retinoid X receptor alpha in colorectal cancer cells (Q33646860) (← links)
• Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells (Q34041309) (← links)
• Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs (Q34234828) (← links)
• Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations (Q34390505) (← links)
• Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis (Q34551546) (← links)
• Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. (Q34808205) (← links)
• Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3. (Q35793857) (← links)
• Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells (Q35892881) (← links)
• Wnt signalling and prostate cancer (Q36089054) (← links)
• Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent (Q36483712) (← links)
• Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors (Q36498885) (← links)
• Mining the Wnt pathway for cancer therapeutics (Q36670448) (← links)
• Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer. (Q38134308) (← links)
• Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells (Q39098613) (← links)
• A novel nitro-oxy substituted analogue of rofecoxib reduces human colon cancer cell growth (Q39457346) (← links)
• The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB. (Q40039714) (← links)
• Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis (Q41075575) (← links)
• Sulindac induces apoptosis and protects against colon carcinoma in mice (Q41891797) (← links)
• Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells (Q42504729) (← links)
• HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1 (Q90334452) (← links)
• Antitumor and antimetastatic effects of licochalcone A in mouse models (Q95806664) (← links)